Defense Department Gives ISB $7.7M to ID Sepsis Biomarkers Using Next-gen Sequencing | GenomeWeb

NEW YORK (GenomeWeb News) – The US Department of Defense today said it has awarded the Institute for Systems Biology a contract for nearly $7.7 million to use next-generation sequencing to identify biomarkers that predict post-operative sepsis during the asymptomatic phase of infection.

The work is being done for DoD's Defense Threat Reduction Agency and is expected to be completed May 29, 2016, DoD said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.